# OnCo record ambagon-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/ambagon-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "ambagon-therapeutics" ;
  schema:name "Ambagon Therapeutics"@en ;
  schema:description "Ambagon Therapeutics designs small molecules that act like glue, locking a hub protein called 14-3-3 onto its partner proteins to switch them on or off. It is an early-stage company with cancer and brain disease programmes."@en ;
  schema:url <https://onco.cc/companies/ambagon-therapeutics/>, <https://www.ambagontx.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.ambagontx.com/>, <https://www.ambagontx.com/platform-pipeline/>, <https://www.sec.gov/Archives/edgar/data/1819934/000181993422000003/primary_doc.xml> ;
  schema:addressCountry "NL" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/drug-discovery/> .